View in EDS HTML Full Text PDF Full Text

Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial.

Saved in:
Bibliographic Details
Title: Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial.
Authors: Burton JO; Division of Cardiovascular Sciences, University of Leicester and University Hospitals of Leicester, Leicester, UK., Izquierdo MJ; Head of Nephrology Department, University Hospital of Burgos, Burgos, Spain., Linde C; Department of Cardiology, Karolinska Institutet, Stockholm, Sweden., Robles NR; Universidad de Extremadura, Head Nephrology Department and Hypertension Unit, Hospital Universitario de Badajoz, Badajoz, Spain., Sood MM; Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada., Allum AM; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Eudicone JM; BioPharmaceuticals Medical Evidence, AstraZeneca, Wilmington, DE, USA., Dahl M; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Amin AN; Department of Medicine, University of California Irvine, Irvine, CA, USA.
Source: Clinical kidney journal [Clin Kidney J] 2026 May 19; Vol. 19 (6), pp. sfag158. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN: 2048-8505 (Print) Linking ISSN: 20488505 NLM ISO Abbreviation: Clin Kidney J Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42338689
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burton+JO%22">Burton JO</searchLink>; Division of Cardiovascular Sciences, University of Leicester and University Hospitals of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Izquierdo+MJ%22">Izquierdo MJ</searchLink>; Head of Nephrology Department, University Hospital of Burgos, Burgos, Spain.<br /><searchLink fieldCode="AU" term="%22Linde+C%22">Linde C</searchLink>; Department of Cardiology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Robles+NR%22">Robles NR</searchLink>; Universidad de Extremadura, Head Nephrology Department and Hypertension Unit, Hospital Universitario de Badajoz, Badajoz, Spain.<br /><searchLink fieldCode="AU" term="%22Sood+MM%22">Sood MM</searchLink>; Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.<br /><searchLink fieldCode="AU" term="%22Allum+AM%22">Allum AM</searchLink>; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Eudicone+JM%22">Eudicone JM</searchLink>; BioPharmaceuticals Medical Evidence, AstraZeneca, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Dahl+M%22">Dahl M</searchLink>; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Amin+AN%22">Amin AN</searchLink>; Department of Medicine, University of California Irvine, Irvine, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101579321%22">Clinical kidney journal</searchLink> [Clin Kidney J] 2026 May 19; Vol. 19 (6), pp. sfag158. <i>Date of Electronic Publication: </i>2026 May 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579321 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2048-8505 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220488505%22">20488505 </searchLink><i>NLM ISO Abbreviation: </i>Clin Kidney J <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42338689
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ckj/sfag158
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: sfag158
    Titles:
      – TitleFull: Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burton JO
      – PersonEntity:
          Name:
            NameFull: Izquierdo MJ
      – PersonEntity:
          Name:
            NameFull: Linde C
      – PersonEntity:
          Name:
            NameFull: Robles NR
      – PersonEntity:
          Name:
            NameFull: Sood MM
      – PersonEntity:
          Name:
            NameFull: Allum AM
      – PersonEntity:
          Name:
            NameFull: Eudicone JM
      – PersonEntity:
          Name:
            NameFull: Dahl M
      – PersonEntity:
          Name:
            NameFull: Amin AN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2026 May 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2048-8505
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical kidney journal
              Type: main
ResultId 1